Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab through Augmentation of Macrophage-Induced ADCP

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original languageEnglish (Ireland)
JournalBlood
Publication statusPublished - 1 Jan 2017

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Aideen Ryan

Cite this